Abstract

BackgroundFibrolamellar carcinoma (FLC) is a rare and fatal liver malignancy that primarily affects otherwise-healthy adolescents and young adults. No curative therapies are currently available, so novel treatments are needed to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call